Substantiation of Rational Choice of Statin Therapy in Ukraine

This study was conducted using marketing, pharmacoeconomical research of statins in Ukraine. It was found that the largest number of people taking statins use atorvastatin (51 %), simvastatin (31 %), rosuvastatin (16 %), lovastatin (2 %). costs minimization, cost-effectiveness and cost-utility analysis it was chose the least costly statins in Ukraine. We found differences in seven Issues of State Formulary of Drugs in Ukraine for the statin groups. The well-founded pharmacoeconomic benefits of rosuvastatin 10 mg included reducing the risk of morbidity and mortality, for atorvasatin 10 mg the reducing of low-density lipoprotein